Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CHNA vs. FACDX: which is better?

Bottom line

CHNA vs FACDX: the short answer

CHNA (Loncar China BioPharma ETF) and FACDX (Fidelity Advisor Health Care Fund) are both etfs.

Updated Nov 19, 2026

CHNA vs FACDX side by side

CHNAFACDX
TypeETFMutual fund
Fund familyGrayscaleFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.96%
Annual cost per $10k—$96
10-yr cost on $10k (prospectus)—$1,685
Max front loadNone—
12b-1 fee—0.25%
1-yr return—+7.7%
5-yr return (annualized)—+2.3%
10-yr return (annualized)—+7.6%
Best quarter—+21.3%
Worst quarter—−15.0%
Net assets (fund)—$3.1B
Number of holdings—154
Portfolio turnover—74%
Returns as of—Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CHNA and FACDX share none of their top holdings.

CHNA top 10

    FACDX top 10

    1. ELI LILLY and CO — 7.66%
    2. Danaher Corp — 6.75%
    3. Thermo Fisher Scientific Inc — 6.31%
    4. Unitedhealth Group Inc — 4.17%
    5. JOHNSON and JOHNSON — 3.78%
    6. Abbvie Inc — 3.62%
    7. Fidelity Revere Street Trust — 2.54%
    8. Argenx Se — 2.09%
    9. MERCK and CO INC — 2.09%
    10. West Pharmaceutical Svcs Inc — 2.06%

    FAQ

    What is the difference between CHNA and FACDX?
    CHNA (Loncar China BioPharma ETF) and FACDX (Fidelity Advisor Health Care Fund) are both etfs.
    Should I own both CHNA and FACDX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.